Bassil F, Fernagut PO, Bezard E, Meissner WG
GLP-1 production occurs along the gut barrier, and a compromised gut barrier will compromise your metabolic health
A direct assessment of the blood pressure in the portal vein clearly showed that NaBPC157, as well as propranolol (given in all of the regimens), markedly prevented and/or decreased the otherwise increased portal blood pressure values in control rats
Effect of one weeks treatment with a GLP-1R Agonist on glycemia and HGP Diabetes, 53:1187;2004 Postprandial metabolism in T2DM with and without DPP-4 inhibition K Azuma, JCEM 2008 Islet cell response to hypoglycemia with and without DPP-4 inhibition Glucagon Vlda 47 ng/L Cntl 34 ng/L ISR Vlda -70 pmol/m2/min Cntl -62 pmol/m2/min PP Vlda 115 pmol/L Cntl 62 pmol/L B Ahren, JCEM 2009 Treatment with Exenatide does not impair the counterregulatory glucagon response Diabetes 53:2397;2004
Our team has seen researchers meticulously time their KLOW doses at 7 AM daily, only to store the vial in a refrigerator that cycles between 4C and 12C due to a failing thermostat